AbbVie stock rises as Wall Street rallies; traders eye Feb. 4 earnings and the Fed next week
AbbVie shares rose 0.9% to $218.11 on Thursday as U.S. stocks rebounded. About 5.7 million AbbVie shares changed hands. Investors await the company’s Feb. 4 earnings report and 2026 outlook, with attention also on the Federal Reserve’s Jan. 27-28 meeting. Markets remain closed until Friday.